No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure

Roy G. de Jong*, Andrea M. Burden, Sander de Kort, Myrthe P. van Herk-Sukel, Pauline A. Vissers, Paddy K. Janssen, Harm R. Haak, Ad A. Masclee, Frank de Vries, Maryska L. Janssen-Heijnen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)290-297
Number of pages8
JournalCancer prevention research
Volume10
Issue number5
DOIs
Publication statusPublished - May 2017

Keywords

  • TYPE-2 DIABETES-MELLITUS
  • PANCREATIC-CANCER
  • COLORECTAL-CANCER
  • ANTIDIABETIC MEDICATIONS
  • REDUCED RISK
  • METAANALYSIS
  • POPULATION
  • COHORT
  • LIVER
  • PREVENTION

Cite this